Here are three stocks positioned nicely to bring gas to hungry markets. These are unprofitable, speculative stocks – with attractive potential attributes – so, as always, do your own homework!

In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk, notes that Morgans has added Pro Medicus (PME) to the Best Ideas List.

Seven magnificent tech giants have powered the rise of the US stock market. They’re now a tick over a third of the benchmark US S&P 500 index. This year they’re off to a mixed start. If you’re c..

Today I’m standing on the shoulders of great business builders to argue that this tech sell off is a buying opportunity. Stay with me on this!

Contrary to media speculation, I can’t see the case for three rate rises this year. If I’m right, REITs could be among the more interesting investment ideas in 2026.

In our “HOT” stock article, Michael Gable, Managing Director of Fairmont Equities, explains why at its current price Worley (WOR) is a buy.

I’m taking the long-term punt on these three quality plays that have been beaten up big time of late

In this article, we look at how our model portfolios have performed so far in 2026.

In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk explains why Morgans regards ResMed (RMD) as a BUY.

Here are three more stocks that look to be good buying opportunities at current prices.